Simplex Trading’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,459
| Closed | -$277K | – | 9225 |
|
|
2026
Q1 | $266K | Sell |
3,459
-693
| -17% | -$54.1K | ﹤0.01% | 3952 |
|
|
2025
Q4 | $328K | Buy |
4,152
+3,540
| +578% | +$307K | ﹤0.01% | 3723 |
|
|
2025
Q3 | $56K | Sell |
612
-1,927
| -76% | -$157K | ﹤0.01% | 6332 |
|
|
2025
Q2 | $165K | Sell |
2,539
-50
| -2% | -$3.25K | ﹤0.01% | 4708 |
|
|
2025
Q1 | $173K | Buy |
+2,589
| New | +$155K | ﹤0.01% | 4489 |
|
|
2024
Q4 | – | Sell |
-621
| Closed | -$37K | – | 8427 |
|
|
2024
Q3 | $37K | Buy |
+621
| New | +$37.9K | ﹤0.01% | 6153 |
|
|
2023
Q1 | – | Sell |
-1,144
| Closed | -$48.2K | – | 8933 |
|
|
2022
Q4 | $46K | Buy |
1,144
+1,104
| +2,760% | +$41.5K | ﹤0.01% | 5982 |
|
|
2022
Q3 | $1K | Buy |
+40
| New | +$1.37K | ﹤0.01% | 9478 |
|
|
2021
Q4 | – | Sell |
-174
| Closed | -$7.48K | – | 10400 |
|
|
2021
Q3 | $6K | Hold |
174
| – | – | ﹤0.01% | 9176 |
|
|
2021
Q2 | $6K | Buy |
174
+120
| +222% | +$4.08K | ﹤0.01% | 9345 |
|
|
2021
Q1 | $1K | Sell |
54
-688
| -93% | -$21.5K | ﹤0.01% | 8528 |
|
|
2020
Q4 | $21K | Buy |
+742
| New | +$21.2K | ﹤0.01% | 6931 |
|
|
2020
Q3 | – | Sell |
-653
| Closed | -$19.4K | – | 7724 |
|
|
2020
Q2 | $21K | Sell |
653
-934
| -59% | -$33.5K | ﹤0.01% | 6168 |
|
|
2020
Q1 | $64K | Sell |
1,587
-317
| -17% | -$16.9K | ﹤0.01% | 4873 |
|
|
2019
Q4 | $117K | Sell |
1,904
-10,211
| -84% | -$676K | ﹤0.01% | 4345 |
|
|
2019
Q3 | $882K | Buy |
12,115
+10,251
| +550% | +$767K | ﹤0.01% | 2052 |
|
|
2019
Q2 | $153K | Sell |
1,864
-2,289
| -55% | -$163K | ﹤0.01% | 3743 |
|
|
2019
Q1 | $292K | Sell |
4,153
-1,371
| -25% | -$80.7K | ﹤0.01% | 3219 |
|
|
2018
Q4 | $248K | Buy |
+5,524
| New | +$290K | ﹤0.01% | 2911 |
|
|
2018
Q1 | – | Sell |
-465
| Closed | -$29.5K | – | 6057 |
|
|
2017
Q4 | $29K | Buy |
+465
| New | +$28.9K | ﹤0.01% | 2948 |
|
|
2017
Q3 | – | Sell |
-4,387
| Closed | -$209K | – | 5833 |
|
|
2017
Q2 | $205K | Buy |
+4,387
| New | +$212K | 0.01% | 1182 |
|
|
2016
Q2 | – | Sell |
-745
| Closed | -$36.2K | – | 5752 |
|
|
2016
Q1 | $25K | Sell |
745
-516
| -41% | -$17.5K | ﹤0.01% | 2587 |
|
|
2015
Q4 | $56K | Sell |
1,261
-2,253
| -64% | -$97K | ﹤0.01% | 1825 |
|
|
2015
Q3 | $138K | Buy |
+3,514
| New | +$200K | 0.01% | 1157 |
|
Other funds holding ANIP
SCM
TCM
GACM
Simplex Trading's ANIP Position: Q2 2026 in Review
Simplex Trading sold out of ANI Pharmaceuticals (ANIP) in Q2 2026, closing a stake of 3,459 shares — an estimated $277K sold.
Simplex Trading first reported a position in ANIP in Q3 2015 and held it in 24 quarters. The position peaked at $882K in Q3 2019. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.
- Simplex Trading reported no remaining ANI Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 3,459 ANI Pharmaceuticals shares in Q2 2026, an estimated $277K.
- Simplex Trading first reported a position in ANI Pharmaceuticals in Q3 2015 and held it in 24 quarters.
- Simplex Trading's ANI Pharmaceuticals position peaked at $882K in Q3 2019.
- 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.